Table 1.
Predictor | na | n of Cases | Odds Ratiob (95% CI) | p Value |
---|---|---|---|---|
Prevalent CHD/Stroke | Outcome: New-onset GHQ symptomsc | |||
No | 12166 | 1461 | 1.0 | |
Yes | 664 | 96 | 1.75 (1.39, 2.21) | <.001 |
Long-Standing Illness (Nonvascular)d | ||||
No | 7095 | 779 | 1.0 | |
Yes | 4884 | 662 | 1.53 (1.37, 1.72) | <.001 |
Prevalent CHD/Stroke | Outcome: New-onset CES-D depressive symptomse | |||
No | 4137 | 253 | 1.0 | |
Yes | 372 | 41 | 2.02 (1.42, 2.98) | <.001 |
Long-Standing Illness (Nonvascular)d | ||||
No | 1787 | 76 | 1.0 | |
Yes | 2293 | 177 | 1.88 (1.41, 2.47) | <.001 |
Prevalent CHD/Stroke | Outcome: Starting antidepressant treatmentc | |||
No | 18430 | 369 | 1.0 | |
Yes | 1191 | 34 | 1.50 (1.04, 2.16) | .03 |
Long-Standing Illness (Nonvascular)d | ||||
No | 10088 | 153 | 1.0 | |
Yes | 7810 | 205 | 1.80 (1.45, 2.23) | <.001 |
CES-D, Center for Epidemiologic Studies Depression Scale; CHD, coronary heart disease; CI, confidence interval; GHQ, General Health Questionnaire.
Number of person observations.
Odds ratios are adjusted for age and sex.
Across three data cycles (from phase 3 to phase 5; from phase 5 to phase 7; from phase 7 to phase 9).
Excluding participants with vascular disease (CHD or stroke).
From phase 7 to phase 9 (one data cycle).